Cathie Wood sells over 38K Palantir shares before earnings

ARK Invest pivots from Palantir to crypto and healthcare plays as tech sector positioning shifts before earnings season.

Photo: Chris Ratcliffe

Key Takeaways

• Cathie Wood’s ARK Invest sold over 38,000 Palantir shares before earnings, reallocating funds to Bullish and Beam Therapeutics.
• The shift reflects ARK’s broader strategy to balance exposure between AI, crypto, and biotech sectors.

<?xml encoding="UTF-8">

Cathie Wood, chief investment officer at ARK Invest, sold over 38,000 Palantir Technologies shares ahead of the AI-driven data analytics firm’s earnings report. The sales were concentrated mainly in ARK’s flagship ETF, ARKK.

ARK Invest has been reallocating capital from Palantir to other assets like Bullish, a crypto exchange operator, with Bullish shares purchased across multiple ARK ETFs. The investment firm is also increasing its positions in companies like Beam Therapeutics while trimming its exposure to Palantir.

Disclaimer